Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONSUS Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cysteine
2. Cysteine Hydrochloride
3. Half Cystine
4. Half-cystine
5. L Cysteine
6. L-cysteine
7. Zinc Cysteinate
1. 52-89-1
2. L-cysteine.hcl
3. L-cysteine Hydrochloride Anhydrous
4. L-cysteine, Hydrochloride
5. L-cysteine Hcl Anhydrous
6. (r)-cysteine Hydrochloride
7. (r)-2-amino-3-mercaptopropanoic Acid Hydrochloride
8. L-cysteine Hcl
9. L-(+)-cysteine Hydrochloride
10. Cysteine Hydrochloride
11. Cysteine Monohydrochloride
12. L-cysteine, Hcl
13. L-cysteine Monohydrochloride
14. Cysteine Hcl
15. Cystein Chloride
16. Cysteine Hcl (anhydrous)
17. Cysteine Hydrochloride (anhydrous)
18. Cysteine, L-, Hydrochloride
19. Cysteine Hydrochloride Anhydrous
20. L-cysteine, Hydrochloride (1:1)
21. Cysteine Chlorhydrate
22. L-cysteine (hydrochloride)
23. H-cys-oh.hcl
24. Nsc 8746
25. A9u1687s1s
26. 3-mercaptoalanine Hydrochloride
27. Ek 2367
28. Cysteine (as Hydrochloride)
29. Ccris 3613
30. Cysteine, L-, Monohydrochloride
31. Nsc-755898
32. Einecs 200-157-7
33. Wr 348
34. Cysteine-hcl
35. Unii-a9u1687s1s
36. Ai3-18781
37. L-cysteine Hydrochloride, Anhydrous
38. Mfcd00064553
39. Cysteine-hydrochloride
40. L-cysteinium Chloride
41. H-cys-oh?cl
42. L-cysteine Chlorhydrate
43. Dsstox_cid_367
44. L-cysteine Hydro-chloride
45. L-cysteine Hydrochloride;
46. Ec 200-157-7
47. Dsstox_rid_75543
48. Dsstox_gsid_20367
49. Schembl18161
50. L-cysteinemethyl Hydrochloride
51. L-2-amino-3-mercaptopropanoic Acid Monohydrochloride
52. Chembl1200630
53. Dtxsid0020367
54. Chebi:91247
55. Hy-y0337a
56. Tox21_200699
57. S4815
58. Akos015849225
59. Ccg-266272
60. Cs-w018517
61. Cysteine Hydrochloride [who-dd]
62. Cas-52-89-1
63. Cysteine Hydrochloride, Anhydrous
64. (r)-(+)-cysteine Hydrochloride Hydrate
65. Ncgc00258253-01
66. (2r)-2-amino-3-mercapto-propionic Acid
67. Ac-12796
68. As-11682
69. L-cysteine Hydrochloride [usp-rs]
70. L-cysteine Hydrochloride, 98.0-102.0%
71. Cysteine Hydrochloride Anhydrous [ii]
72. Cysteine Hydrochloride Anhydrous [mi]
73. (r)2-amino-3-thiopropanoic Acid Hydrochloride
74. E72644
75. (r)-2-amino-3-mercaptopropanoicacidhydrochloride
76. 064c553
77. A829298
78. (1r)-1-carboxy-2-sulfanylethan-1-aminium Chloride
79. (2r)-2-amino-3-sulfanylpropanoic Acid;hydrochloride
80. J-019666
81. L-cysteine Hydrochloride, Anhydrous, >=98% (tlc)
82. W-105789
83. L-cysteine Hydrochloride, Anhydrous, >=99.0% (rt)
84. Q27163158
85. L-cysteine Hydrochloride, Fg, Product Of Wacker Chemie Ag
86. L-cysteine Hydrochloride, Vetec(tm) Reagent Grade, >=98%
87. (2r)-2-amino-3-sulfanyl-propanoic Acid Hydrochloride;h-cys-oh.hcl
88. L-cysteine Hydrochloride, Anhydrous, From Non-animal Source, Bioreagent, Suitable For Cell Culture, >=98.0%
| Molecular Weight | 157.62 g/mol |
|---|---|
| Molecular Formula | C3H8ClNO2S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 156.9964274 g/mol |
| Monoisotopic Mass | 156.9964274 g/mol |
| Topological Polar Surface Area | 64.3 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 75.3 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
Axplora is your partner of choice for complex APIs.
Certificate Number : R1-CEP 1997-014 - Rev 03
Issue Date : 2014-04-24
Type : Chemical
Substance Number : 895
Status : Valid
| Available Reg Filing : EU |
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
NDC Package Code : 10695-128
Start Marketing Date : 2024-06-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Anlon Healthcare manufactures high-quality Pharmaceutical Bulk Drugs & Intermediates compliant with FDA, PMDA, KFDA, cGMP & WHO-GMP.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-08-14
Pay. Date : 2018-07-02
DMF Number : 21364
Submission : 2008-02-26
Status : Active
Type : II
Registration Number : 220MF10016
Registrant's Address : 575-1 Shimada-cho, Ashikaga City, Tochigi Prefecture
Initial Date of Registration : 2008-01-09
Latest Date of Registration :
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-10-27
Pay. Date : 2017-03-14
DMF Number : 8866
Submission : 1990-11-30
Status : Active
Type : II
Registration Number : 220MF10229
Registrant's Address : 452 Oshiba, Mobara City, Chiba Prefecture
Initial Date of Registration : 2008-11-17
Latest Date of Registration :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2753
Submission : 1976-10-15
Status : Inactive
Type : II
NDC Package Code : 12497-1013
Start Marketing Date : 1978-03-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1930
Submission : 1972-05-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10741
Submission : 1994-02-28
Status : Inactive
Type : II
NDC Package Code : 17333-909
Start Marketing Date : 2008-06-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2753
Submission : 1976-10-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1930
Submission : 1972-05-09
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-08-14
Pay. Date : 2018-07-02
DMF Number : 21364
Submission : 2008-02-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10741
Submission : 1994-02-28
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-10-27
Pay. Date : 2017-03-14
DMF Number : 8866
Submission : 1990-11-30
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Axplora is your partner of choice for complex APIs.
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...
Anlon Healthcare manufactures high-quality Pharmaceutical Bulk Drugs & Intermediates compliant with FDA, PMDA, KFDA, cGMP & WHO-GMP.
About the Company : Anlon Healthcare is a research-focused pharmaceutical manufacturer based in Rajkot, specializing in bulk drugs and intermediates. The company’s products comply with international...
About the Company : The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practic...
L-Cysteine Hydrochloride Monohydrate
About the Company : Apotex Pharmachem is a global fully integrated API R&D and manufacturing organization with its headquarters located in Brantford, Ontario, Canada and is a member of the Apotex grou...
L-Cysteine Hydrochloride Monohydrate
About the Company : We specialize in the supply of API and API related intermediates and services. A significant part of our business comes from the process/production development tailored to our cust...
About the Company : Tianjin Tianfa Pharmaceutical Import & Export Co., Ltd. (Tianfa) was established in April 2000 and is jointly funded by Tianjin Pharmaceutical Group Co., Ltd. and Jinyao Pharmaceut...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - 2500MG/50ML (...DOSAGE - SOLUTION;INTRAVENOUS - 2500MG/50ML (50MG/ML)
USFDA APPLICATION NUMBER - 210660
DOSAGE - SOLUTION;INTRAVENOUS - 500MG/10ML (5...DOSAGE - SOLUTION;INTRAVENOUS - 500MG/10ML (50MG/ML)
USFDA APPLICATION NUMBER - 210660
Digital Content
NEWS #PharmaBuzz
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
84
PharmaCompass offers a list of L-Cysteine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Cysteine Hydrochloride manufacturer or L-Cysteine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Cysteine Hydrochloride manufacturer or L-Cysteine Hydrochloride supplier.
PharmaCompass also assists you with knowing the L-Cysteine Hydrochloride API Price utilized in the formulation of products. L-Cysteine Hydrochloride API Price is not always fixed or binding as the L-Cysteine Hydrochloride Price is obtained through a variety of data sources. The L-Cysteine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L-Cysteine Hydrochloride Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Cysteine Hydrochloride Monohydrate, including repackagers and relabelers. The FDA regulates L-Cysteine Hydrochloride Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Cysteine Hydrochloride Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Cysteine Hydrochloride Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Cysteine Hydrochloride Monohydrate supplier is an individual or a company that provides L-Cysteine Hydrochloride Monohydrate active pharmaceutical ingredient (API) or L-Cysteine Hydrochloride Monohydrate finished formulations upon request. The L-Cysteine Hydrochloride Monohydrate suppliers may include L-Cysteine Hydrochloride Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L-Cysteine Hydrochloride Monohydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Cysteine Hydrochloride Monohydrate active pharmaceutical ingredient (API) in detail. Different forms of L-Cysteine Hydrochloride Monohydrate DMFs exist exist since differing nations have different regulations, such as L-Cysteine Hydrochloride Monohydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Cysteine Hydrochloride Monohydrate DMF submitted to regulatory agencies in the US is known as a USDMF. L-Cysteine Hydrochloride Monohydrate USDMF includes data on L-Cysteine Hydrochloride Monohydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Cysteine Hydrochloride Monohydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The L-Cysteine Hydrochloride Monohydrate Drug Master File in Japan (L-Cysteine Hydrochloride Monohydrate JDMF) empowers L-Cysteine Hydrochloride Monohydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the L-Cysteine Hydrochloride Monohydrate JDMF during the approval evaluation for pharmaceutical products. At the time of L-Cysteine Hydrochloride Monohydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with JDMF on PharmaCompass.
A L-Cysteine Hydrochloride Monohydrate CEP of the European Pharmacopoeia monograph is often referred to as a L-Cysteine Hydrochloride Monohydrate Certificate of Suitability (COS). The purpose of a L-Cysteine Hydrochloride Monohydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of L-Cysteine Hydrochloride Monohydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of L-Cysteine Hydrochloride Monohydrate to their clients by showing that a L-Cysteine Hydrochloride Monohydrate CEP has been issued for it. The manufacturer submits a L-Cysteine Hydrochloride Monohydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a L-Cysteine Hydrochloride Monohydrate CEP holder for the record. Additionally, the data presented in the L-Cysteine Hydrochloride Monohydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the L-Cysteine Hydrochloride Monohydrate DMF.
A L-Cysteine Hydrochloride Monohydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. L-Cysteine Hydrochloride Monohydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L-Cysteine Hydrochloride Monohydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L-Cysteine Hydrochloride Monohydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L-Cysteine Hydrochloride Monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L-Cysteine Hydrochloride Monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L-Cysteine Hydrochloride Monohydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L-Cysteine Hydrochloride Monohydrate suppliers with NDC on PharmaCompass.
L-Cysteine Hydrochloride Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Cysteine Hydrochloride Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Cysteine Hydrochloride Monohydrate GMP manufacturer or L-Cysteine Hydrochloride Monohydrate GMP API supplier for your needs.
A L-Cysteine Hydrochloride Monohydrate CoA (Certificate of Analysis) is a formal document that attests to L-Cysteine Hydrochloride Monohydrate's compliance with L-Cysteine Hydrochloride Monohydrate specifications and serves as a tool for batch-level quality control.
L-Cysteine Hydrochloride Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each L-Cysteine Hydrochloride Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Cysteine Hydrochloride Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Cysteine Hydrochloride Monohydrate EP), L-Cysteine Hydrochloride Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Cysteine Hydrochloride Monohydrate USP).
